Company Filing History:
Years Active: 2019-2023
Title: Innovations by Charles Shiner in Therapeutic Risk Management
Introduction
Charles Shiner, an inventive mind based in Collegeville, PA, is recognized for his significant contributions to the field of therapeutic risk management. With a total of two patents to his name, Shiner has demonstrated a commitment to enhancing patient safety through innovative technologies.
Latest Patents
Among his most notable inventions is a device-based risk management system (RMS) designed for the administration of therapeutic agents with multiple indications. This sophisticated RMS device comprises a database and a processor equipped with various modules. The prescriber module facilitates the enrollment of patients into the RMS program by processing requests that specify particular indications, along with confirmation of necessary diagnostic tests. The patient module creates individualized patient profiles, which are subsequently stored in the RMS database. Additionally, the authorization module generates codes determining patient eligibility for therapeutic agents, while the communication module ensures that these codes are effectively transmitted to pharmacies or prescribers.
Career Highlights
Charles Shiner is currently affiliated with Otsuka Pharmaceutical Company, Limited, where he applies his expertise in risk management to advance therapeutic methodologies. His work combines innovative technology and healthcare solutions, directly impacting patient care and safety.
Collaborations
In his professional journey, Shiner has collaborated with esteemed colleagues such as Frank S. Czerwiec and Amy Freedman. These partnerships have fostered a collaborative environment that highlights the importance of teamwork in driving innovation within the pharmaceutical industry.
Conclusion
In summary, Charles Shiner stands out as a prominent inventor in the realm of therapeutic risk management. Through his innovative patents and collaborative efforts at Otsuka Pharmaceutical Company, Limited, he continues to contribute significantly to advancements in patient care and safety, shaping the future of therapeutic practices.